Literature DB >> 2960685

Neutrophil C3bi receptors: formation of membrane clusters during cell triggering requires intracellular granules.

H R Petty1, J W Francis, R F Todd, P Petrequin, L A Boxer.   

Abstract

Video-intensification fluorescence microscopy has been used to study the cell surface distribution of the complement receptor (CR) for C3bi (CR3) on human neutrophils. Fluorescein- or rhodamine-labeled monoclonal IgG or Fab fragments of antireceptor antibody were used as probes of receptor localization. C3bi receptors are uniformly distributed on untreated cells. Glass coverslips were coated with lipopolysaccharide (LPS) and serum was added; the serum deposits complement components, including C3bi, on the surface. When neutrophils were adherent to these coverslips, receptors were found in large clusters, and a fraction of the fluorescence remained uniform. Double-labeling studies were conducted by first labeling with anti-CR3 followed by attachment to LPS/serum-treated slides. This, in turn, was followed by labeling with the antibody conjugated to a second fluorophore. These studies revealed that the CR3 clusters were predominantly new antigenic sites exposed after attachment to the LPS/serum-treated slides. To determine the contribution of granule-associated CR3, we have studied neutrophils defective in receptor up-regulation, neutrophil cytoplasts, and a stimulator of granule release, A23187. Neutrophils from a patient with specific granule deficiency were found to be defective in granular CR3 and did not form clusters on C3-modified surfaces. The patient's neutrophils were defective in CR3 up-regulation and enzyme release as shown by fluorescence flow cytometry and gelatinase release, respectively. Cytoplasts also failed to show CR3 clusters on LPS/serum-treated coverslips. Furthermore, neutrophils treated with A23187 demonstrated numerous CR3 clusters. We suggest that formation of CR3 membrane domains during immune recognition requires the participation of intracellular granules. We speculate that these domains are formed by fusion of CR3-bearing granules at local sites of adhesion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960685     DOI: 10.1002/jcp.1041330206

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Surface Mo1 (CD11b/CD18) glycoprotein is up-modulated by neutrophils recruited to sites of inflammation in vivo.

Authors:  D R Freyer; M L Morganroth; R F Todd
Journal:  Inflammation       Date:  1989-10       Impact factor: 4.092

2.  TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression.

Authors:  Susan G Elner; Howard R Petty; Victor M Elner; Ayako Yoshida; Zong-Mei Bian; Dongli Yang; Andrei L Kindezelskii
Journal:  Trans Am Ophthalmol Soc       Date:  2005

3.  Selective defect in myeloid cell lactoferrin gene expression in neutrophil specific granule deficiency.

Authors:  K J Lomax; J I Gallin; D Rotrosen; G D Raphael; M A Kaliner; E J Benz; L A Boxer; H L Malech
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.

Authors:  C W Smith; S D Marlin; R Rothlein; C Toman; D C Anderson
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

5.  Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion.

Authors:  B J Hughes; J C Hollers; E Crockett-Torabi; C W Smith
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

6.  Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase.

Authors:  Susan G Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2002

7.  Neutrophil adherence to isolated adult canine myocytes. Evidence for a CD18-dependent mechanism.

Authors:  M L Entman; K Youker; S B Shappell; C Siegel; R Rothlein; W J Dreyer; F C Schmalstieg; C W Smith
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.